A detailed history of Farallon Capital Management LLC transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Farallon Capital Management LLC holds 2,108,262 shares of ENTA stock, worth $19.7 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
2,108,262
Previous 2,095,000 0.63%
Holding current value
$19.7 Million
Previous $27.2 Million 19.54%
% of portfolio
0.11%
Previous 0.13%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.05 - $16.54 $133,283 - $219,353
13,262 Added 0.63%
2,108,262 $21.9 Million
Q1 2024

May 15, 2024

BUY
$10.08 - $17.46 $705,600 - $1.22 Million
70,000 Added 3.46%
2,095,000 $36.6 Million
Q4 2023

Feb 14, 2024

BUY
$8.18 - $10.78 $16.6 Million - $21.8 Million
2,025,000 New
2,025,000 $19.1 Million
Q3 2023

Nov 14, 2023

BUY
$11.09 - $22.13 $20.8 Million - $41.5 Million
1,875,000 New
1,875,000 $20.9 Million
Q2 2023

Aug 14, 2023

BUY
$20.68 - $39.85 $6.72 Million - $13 Million
325,000 Added 20.97%
1,875,000 $40.1 Million
Q1 2022

May 16, 2022

SELL
$56.06 - $74.11 $1.34 Million - $1.77 Million
-23,829 Reduced 1.51%
1,550,000 $110 Million
Q4 2021

Feb 14, 2022

SELL
$60.19 - $97.37 $25.4 Million - $41 Million
-421,171 Reduced 21.11%
1,573,829 $118 Million
Q1 2021

May 17, 2021

BUY
$41.69 - $54.95 $9.17 Million - $12.1 Million
220,000 Added 12.39%
1,995,000 $98.4 Million
Q3 2020

Nov 16, 2020

BUY
$43.36 - $53.53 $1.08 Million - $1.34 Million
25,000 Added 1.43%
1,775,000 $81.3 Million
Q4 2019

Feb 13, 2020

BUY
$57.95 - $66.61 $27.6 Million - $31.7 Million
475,788 Added 37.34%
1,750,000 $108 Million
Q3 2019

Nov 14, 2019

BUY
$60.08 - $88.17 $18.9 Million - $27.7 Million
314,212 Added 32.73%
1,274,212 $76.6 Million
Q2 2019

Aug 14, 2019

BUY
$81.3 - $97.35 $1.63 Million - $1.95 Million
20,000 Added 2.13%
960,000 $81 Million
Q1 2019

May 15, 2019

BUY
$69.08 - $105.66 $1.04 Million - $1.58 Million
15,000 Added 1.62%
940,000 $89.8 Million
Q4 2018

Feb 14, 2019

BUY
$65.41 - $84.65 $3.76 Million - $4.87 Million
57,500 Added 6.63%
925,000 $65.5 Million
Q3 2018

Nov 14, 2018

SELL
$85.46 - $126.37 $17.7 Million - $26.2 Million
-207,500 Reduced 19.3%
867,500 $74.1 Million
Q2 2018

Aug 14, 2018

BUY
$81.85 - $120.51 $13.1 Million - $19.3 Million
160,000 Added 17.49%
1,075,000 $125 Million
Q1 2018

May 15, 2018

SELL
$57.91 - $92.15 $579,100 - $921,500
-10,000 Reduced 1.08%
915,000 $74 Million
Q4 2017

Feb 14, 2018

BUY
$45.65 - $59.37 $23.4 Million - $30.4 Million
512,667 Added 124.33%
925,000 $54.3 Million
Q3 2017

Nov 14, 2017

BUY
$37.91 - $46.8 $15.6 Million - $19.3 Million
412,333
412,333 $19.3 Million

Others Institutions Holding ENTA

About ENANTA PHARMACEUTICALS INC


  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $194M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Farallon Capital Management LLC Portfolio

Follow Farallon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.